Regulatory, quality and health risk considerations for infection-control products
First written in FY2021-Q3. 1 of 2 entries say "Restated". Latest entry: FY2021.
No other company in this theme has enough history to compare yet.
- FY2021RestatedAnnual report
「If, during the provision of products or services in the infectious disease prevention business, a situation arises in which consumers suffer health damage due to defective quality or other causes, our group's operating results and other matters may be affected by lower sales, the incurrence of damages claims or damage to our group's brand image.」
The company continues to disclose the risks of health damage due to defective quality, lower sales, damages claims and brand damage in the infectious disease prevention business. - FY2021-Q3First statedAnnual report
「If, during the provision of products or services in the infectious disease prevention business, a situation arises in which consumers suffer health damage due to defective quality or other causes, our group's operating results and other matters may be affected by lower sales, the incurrence of damages claims or damage to our group's brand image.」
For the newly launched infectious disease prevention business, the company disclosed the possibility of consumer health damage due to defective quality, lower sales, damages claims and damage to its brand image as separate risks.